4 April 2018 - Deborah Wilkes
Archived
Maxwellia has raised early-stage investment worth GBP0.70 million (USD0.98 million) to fund its ambitious programme of switching medicines from prescription-to-OTC status
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.